Acorah Software Products - Accounts Production 16.2.850 false true 31 August 2023 1 September 2022 false 1 September 2023 31 August 2024 31 August 2024 12829436 Mohammed Mahdi Mohammed Mahdi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12829436 2023-08-31 12829436 2024-08-31 12829436 2023-09-01 2024-08-31 12829436 frs-core:CurrentFinancialInstruments 2024-08-31 12829436 frs-core:Non-currentFinancialInstruments 2024-08-31 12829436 frs-core:ShareCapital 2024-08-31 12829436 frs-core:RetainedEarningsAccumulatedLosses 2024-08-31 12829436 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 12829436 frs-bus:FilletedAccounts 2023-09-01 2024-08-31 12829436 frs-bus:SmallEntities 2023-09-01 2024-08-31 12829436 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 12829436 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 12829436 frs-bus:Director1 2023-09-01 2024-08-31 12829436 frs-bus:CompanySecretary1 2023-09-01 2024-08-31 12829436 frs-countries:EnglandWales 2023-09-01 2024-08-31 12829436 2022-08-31 12829436 2023-08-31 12829436 2022-09-01 2023-08-31 12829436 frs-core:CurrentFinancialInstruments 2023-08-31 12829436 frs-core:Non-currentFinancialInstruments 2023-08-31 12829436 frs-core:ShareCapital 2023-08-31 12829436 frs-core:RetainedEarningsAccumulatedLosses 2023-08-31
Registered number: 12829436
GENERIC PLUS PHARMACEUTICALS LTD
Unaudited Financial Statements
For The Year Ended 31 August 2024
Wizz Accounting Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 12829436
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 1,000 1,000
1,000 1,000
Creditors: Amounts Falling Due Within One Year 5 (512 ) (512 )
NET CURRENT ASSETS (LIABILITIES) 488 488
TOTAL ASSETS LESS CURRENT LIABILITIES 488 488
Creditors: Amounts Falling Due After More Than One Year 6 (106 ) -
NET ASSETS 382 488
CAPITAL AND RESERVES
Called up share capital 7 1,000 1,000
Profit and Loss Account (618 ) (512 )
SHAREHOLDERS' FUNDS 382 488
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mohammed Mahdi
Director
3 June 2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
GENERIC PLUS PHARMACEUTICALS LTD is a private company, limited by shares, incorporated in England & Wales, registered number 12829436 . The registered office is C/O Taxaccolega, 187a London Road, Croydon, CR0 2RJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Debtors
2024 2023
£ £
Due within one year
Other debtors 1,000 1,000
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Other creditors 512 512
6. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Other creditors 106 -
7. Share Capital
2024 2023
£ £
Called Up Share Capital not Paid 1,000 1,000
Amount of Allotted, Called Up Share Capital 1,000 1,000
Page 2